We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) DIBENZYLINE phenoxybenzamine hydrochloride 10mg capsule, USP
Section 19A approved medicine
(Approval lapsed) DIBENZYLINE phenoxybenzamine hydrochloride 10mg capsule, USP
Section 19A approval holder
Boucher and Muir Pty Ltd trading as BNM Group ABN 58 000 140 474
Phone
02 9431 6333
Approved until
Status
Expired
Medicines in short supply/unavailable
DIBENYLINE phenoxybenzamine hydrochloride 10mg capsule jar - ARTG 12980
Indication(s)
Dibenzyline is indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating.
Additional information